全文获取类型
收费全文 | 21831篇 |
免费 | 1544篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 537篇 |
儿科学 | 712篇 |
妇产科学 | 389篇 |
基础医学 | 3687篇 |
口腔科学 | 358篇 |
临床医学 | 2144篇 |
内科学 | 4200篇 |
皮肤病学 | 718篇 |
神经病学 | 2301篇 |
特种医学 | 758篇 |
外国民族医学 | 1篇 |
外科学 | 2725篇 |
综合类 | 290篇 |
现状与发展 | 1篇 |
一般理论 | 15篇 |
预防医学 | 1338篇 |
眼科学 | 473篇 |
药学 | 1391篇 |
中国医学 | 62篇 |
肿瘤学 | 1312篇 |
出版年
2022年 | 126篇 |
2021年 | 288篇 |
2020年 | 227篇 |
2019年 | 284篇 |
2018年 | 316篇 |
2017年 | 250篇 |
2016年 | 321篇 |
2015年 | 362篇 |
2014年 | 501篇 |
2013年 | 738篇 |
2012年 | 1023篇 |
2011年 | 1140篇 |
2010年 | 723篇 |
2009年 | 592篇 |
2008年 | 1064篇 |
2007年 | 1114篇 |
2006年 | 1075篇 |
2005年 | 1198篇 |
2004年 | 1022篇 |
2003年 | 968篇 |
2002年 | 960篇 |
2001年 | 407篇 |
2000年 | 399篇 |
1999年 | 374篇 |
1998年 | 291篇 |
1997年 | 257篇 |
1996年 | 215篇 |
1995年 | 183篇 |
1994年 | 188篇 |
1993年 | 168篇 |
1992年 | 235篇 |
1991年 | 231篇 |
1990年 | 231篇 |
1989年 | 216篇 |
1988年 | 196篇 |
1987年 | 202篇 |
1986年 | 183篇 |
1985年 | 180篇 |
1984年 | 151篇 |
1983年 | 162篇 |
1982年 | 181篇 |
1981年 | 189篇 |
1980年 | 169篇 |
1979年 | 169篇 |
1978年 | 140篇 |
1977年 | 158篇 |
1976年 | 151篇 |
1975年 | 112篇 |
1974年 | 155篇 |
1973年 | 113篇 |
排序方式: 共有10000条查询结果,搜索用时 625 毫秒
21.
Judith D. Goldberg Arnold I. Weiss Kenneth J. Koury 《Journal of clinical periodontology》1986,13(5):411-414
In order to make effective use of the statistical theory of design of clinical trials for chronic diseases such as periodontal disease, certain issues must be considered. Any clinical trial requires that the disease definition be well-specified; that patient eligibility be explicit; that the observation times be explicit; that the duration and endpoint of therapy be specified; that the duration of subsequent followup observation be specified; and that the unit of observation (e.g., tooth, set of teeth, patient) be defined. In a chronic disease, the potential biases that can readily be introduced by self-selection of patients who enter the trial and/or who return for subsequent observation become more important, because subjects are required to remain on treatment and/or observation for prolonged periods. Further, the cyclical nature of some chronic diseases may require special attention to baseline definitions of active disease and disease outcome. These issues are illustrated with examples from clinical trials of hypertension, breast cancer screening, and Polycythemia Vera. Implications for periodontal disease are discussed. 相似文献
22.
David S. Ball D.O. Arnold C. Friedman David S. Hartman Paul D. Radecki Dina F. Caroline 《Urologic radiology》1986,8(1):46-48
This case report illustrates the magnetic resonance imaging (MRI) appearance of a typically asymptomatic renal oncocytoma as a homogeneous mass of medium signal with a stellate central region of decreased signal, representing the central scar. The MRI was correlated with computed tomography (CT), ultrasound (US), and gross pathologic appearance. The appearance of a central scar is not specific for oncocytoma and does not exclude renal cell carcinoma, as illustrated by a second case. 相似文献
23.
Dr. Rudolf Trompke 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》1949,263(1-2):164-179
Ohne Zusammenfassung 相似文献
24.
Ulrich Weber Christian WA Pfirrmann Rudolf O Kissling Juerg Hodler Marco Zanetti 《BMC musculoskeletal disorders》2007,8(1):20
Background
Ankylosing spondylitis is a chronic inflammatory rheumatic disorder which usually begins in early adulthood. The diagnosis is often delayed by many years. MR imaging has become the preferred imaging method for detection of early inflammation of the axial skeleton in ankylosing spondylitis. 相似文献25.
26.
Isolde Hausser Wilhelm Doerr Rudolf Frey Adolf Ueberle 《Journal of cancer research and clinical oncology》1949,56(4-5):449-481
Ohne ZusammenfassungMit 24 Textabbildungen.Vorgetragen: 1. I. Hausser, Ultraschall-Arbeitstagung Erlangen, 3. 5. 49; s. Kongreßbericht. 2. W. Doerr, ebendort; infolge Erkrankung vertreten durch I. Hausser. 3. R. Frey, Deutscher Chirurgenkongreß in Frankfurt, 9. 6. 49. 相似文献
27.
Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PET. 总被引:1,自引:0,他引:1
Jens P Bankstahl Claudia Kuntner Aiman Abrahim Rudolf Karch Johann Stanek Thomas Wanek Wolfgang Wadsak Kurt Kletter Markus Müller Wolfgang L?scher Oliver Langer 《Journal of nuclear medicine》2008,49(8):1328-1335
The multidrug efflux transporter P-glycoprotein (P-gp) is expressed in high concentrations at the blood-brain barrier (BBB) and is believed to be implicated in resistance to central nervous system drugs. We used small-animal PET and (R)-11C-verapamil together with tariquidar, a new-generation P-gp modulator, to study the functional activity of P-gp at the BBB of rats. To enable a comparison with human PET data, we performed kinetic modeling to estimate the rate constants of radiotracer transport across the rat BBB. METHODS: A group of 7 Wistar Unilever rats underwent paired (R)-11C-verapamil PET scans at an interval of 3 h: 1 baseline scan and 1 scan after intravenous injection of tariquidar (15 mg/kg, n = 5) or vehicle (n = 2). RESULTS: After tariquidar administration, the distribution volume (DV) of (R)-11C-verapamil was 12-fold higher than baseline (3.68 +/- 0.81 vs. 0.30 +/- 0.08; P = 0.0007, paired t test), whereas the DVs were essentially the same when only vehicle was administered. The increase in DV could be attributed mainly to an increased influx rate constant (K1) of (R)-11C-verapamil into the brain, which was about 8-fold higher after tariquidar. A dose-response assessment with tariquidar provided an estimated half-maximum effect dose of 8.4 +/- 9.5 mg/kg. CONCLUSION: Our data demonstrate that (R)-11C-verapamil PET combined with tariquidar administration is a promising approach to measure P-gp function at the BBB. 相似文献
28.
Arnold Smiatek 《Naunyn-Schmiedeberg's archives of pharmacology》1939,193(5-6):547-550
Zusammenfassung Bei Dauerinfusion mit r- und l-Veritol ergibt sich, daß die Wirkung der l-Modifikation länger bestehen bleibt als die der optischen isomeren Verbindung. Die Wirkung von Ephedrin bei dem gleichen Effekt erschöpft sich schon viel früher.Mit 1 Textabbildung. 相似文献
29.
30.
OBJECTIVE: Based on recent safety and efficacy data, combined with the known pharmacokinetic parameters of aminoglycosides in the newborn, once-daily gentamicin should be preferable to the many other dosing regimens currently in use. Although there are growing data to support its use in term newborns, experience with preterm infants is more limited. In our Neonatal Intensive Care Unit, we experienced difficulties regarding complicated dosing regimens, actual dosing errors, and the tendency to check trough and peak levels around the third dose for infants receiving only a 48 hour course. Therefore, we conducted a quality improvement initiative in which we developed and tested a clinical practice guideline for the use of once-daily gentamicin for preterm and term infants that we hoped would yield trough and peak levels in our target range. METHODS: We combined a review of the published English language literature with pharmacokinetic analysis of our own data prior to initiation of this new regimen to design the following dosing regimen: <35 weeks gestation: 3 mg/kg q 24 hours, > or =35 weeks gestation: 4 mg/kg q 24 hours. Our goal serum levels were a trough < or =2 microg/ml and a peak between 6 and 12 microg/ml. We collected and analyzed trough and peak levels from all infants receiving this dosing regimen in the first week of life for at least 72 hours between 3/1/99 and 12/31/00. RESULTS: In total, 214 babies met our inclusion criteria, 75 of whom were <35 weeks gestation. 100% of babies of all gestational ages had a nontoxic trough level. For infants <35 weeks gestation, 79% had a therapeutic peak level, with a mean value of 6.8 microg/ml. For infants of at least 35 weeks gestation, 93% had a therapeutic peak level, with a mean value of 8.4 microg/ml. 92% of nontherapeutic peaks were too low. CONCLUSION: This study of once-daily gentamicin represents the largest sample size of pre-term infants published to date. The proposed regimen is simple and yields a high proportion of desirable levels. We recommend it for use in preterm and term newborns. 相似文献